Gregory S. Morrison
Lawyers
Advises clients on antitrust M&A, government investigations and litigation.
Gregory assists clients in navigating the U.S. merger control regime from a substantive and strategic perspective and in complying with U.S. and global merger control obligations. He also represents clients in non-merger conduct investigations by the antitrust agencies, including cartel matters, and in antitrust civil litigations.
Gregory routinely represents clients in matters before the U.S. Department of Justice and Federal Trade Commission, as well as in antitrust litigation before courts in a variety of U.S. jurisdictions.
Experience
Recent Work
- FTC clearance of Novo Nordisk acquisition of certain Catalent sites
- Lightyear GP-led secondary transaction and formation of continuation fund
- Novo Nordisk acquisition of certain Catalent sites from Novo Holdings
- Cano Health amendment and covenant waiver for side-car credit facility
- Cellular Biomedicine Group CAR-T collaboration and license agreement with Janssen
- Japan Industrial Partners $15.2 billion acquisition of Toshiba
- SCANA Special Litigation Committee in nuclear facility investigation
- Aetna receives DOJ approval of $77 billion acquisition by CVS Health
- Davis Polk Advises Aetna on the U.S. Department of Justice Approval of Its Acquisition by CVS Health
Insights
Education
J.D., George Washington University Law School
- summa cum laude
- Notes and Projects Editor, George Washington Law Review
A.B., History and Public Policy, Duke University
- cum laude
Clerkships
Law Clerk, Hon. Henry F. Floyd, U.S. Court of Appeals, Fourth Circuit, 2015-2016
Law Clerk, Hon. Margaret B. Seymour, U.S. District Court, South Carolina, 2014-2015
Qualifications and admissions
- State of New York
- State of South Carolina
- U.S. Court of Appeals, Fourth Circuit
- U.S. District Court, E.D. New York
- U.S. District Court, S.D. New York
- U.S. District Court, South Carolina